For generations, the Klingenstein family has valued family involvement, patience and discipline, scientific research, measurable results, the advice of experts, and the joy that comes from helping make a difference in people’s lives.
Tackling important issues to benefit people
Klingenstein Philanthropies is committed to helping people by supporting breakthrough research in neuroscience, and by funding programs that improve the lives of children, especially in the fields of mental health, oral health, medicine, and education.
Disciplined commitments to our areas of focus
The areas we commit to are challenging and do not lend themselves to easy answers or quick fixes. They require patience and a long-term perspective. Once the decision has been made to get involved in a field, we tend to stay the course.
Current Funding Opportunities
We’re grateful for our partners in neuroscience, children’s health, and independent education. Please look through the current funding opportunities to see if there is an opportunity for us to work together.
Prior Klingenstein Neuroscience Fellows Win the Japan Prize
Congratulations Gero Miesenböck and Karl Deisseroth co-winners of the Japan Prize in the field of Life Sciences. Dr. Miesenböck and Dr. Deisseroth are being recognized for their development of methods that use genetically addressable light-sensitive membrane proteins to unravel neural circuit function. Dr. Miesenböck received his Klingenstein Neuroscience Fellowship in 2000, and Dr. Deisseroth in […]
Prior Klingenstein-Simons Fellow Receives NAS Troland Award
Congratulations to Catherine Hartley, 2017 Klingenstein-Simons Fellow and winner of a 2023 the National Academy of Sciences Troland Research Award for novel contributions to the understanding of the adolescent mind and brain. Troland Research Awards are given annually to recognize unusual achievement by early-career researchers and to further empirical research within the broad spectrum of […]
2018 Klingenstein Third Generation Foundation Fellow Recognized by the ADAA
Emily Belleau, PhD has received the 2023 Anxiety and Depression Association of America’s (ADAA) Donald F. Klein Early Career Investigator Award for the best original research paper on neurobiology, psychopharmacology, psychosocial treatments, or experimental psychopathology of anxiety disorders and depression. Read more about Dr. Belleau’s research and award.
We wish to honor several generations of the Klingenstein family, past and present, as we bring together our longstanding areas of interest with our more recent work to improve the lives of those in need.